Sign in

Back to the bill

89th General Assembly · Iowa Funnel one-pager · Monday, November 9, 2026

HSB 690: HSB 690

Became HF 2539 · Its progress continues under the new number.

Sponsors

Not listed

Cost

See the fiscal note

1 million. Operating costs to continue administering the three additional tests are estimated to be approximately $714,000 per year. 80.

House subcommittee · named February 9, 2022

  • Rep. Ann Meyer (R) · ann.meyer@legis.iowa.gov
  • Rep. Steven P. Bradley (R) · steven.bradley@legis.iowa.gov
  • Rep. Kristin Sunde (D)

Lobbying · 13 for, 0 against

For: Every Life Foundation for Rare Diseases; EveryStep; Genentech, Inc., A Member of the Roche Group; Iowa Biotechnology Association; Iowa Chapter of the National Association of Pediatric Nurse Practitioners; Iowa Developmental Disabilities Council; Iowa Nurse Practitioners Society; Pfizer Inc. c/o Politicom Law LLP; Sanofi US; The Family Leader; The Family Leader Foundation; Ultragenyx Pharmaceutical Inc.; and 1 more

In plain words

  1. February 9, 2022Filed in the House and sent to the Human Resources committee
  2. February 9, 2022House subcommittee named: Meyer, A., Bradley and Sunde
  3. February 10, 2022Subcommittee recommended passing it with changes
  4. February 17, 2022Approved by the House committee
  5. February 28, 2022Approved by the House committee, and given a new number: HF 2539

From public records at legis.iowa.gov, compiled by Iowa Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/89/HSB690